DK1147420T3 - Urintrypsininhibitor til diagnosticering af AIDS - Google Patents

Urintrypsininhibitor til diagnosticering af AIDS

Info

Publication number
DK1147420T3
DK1147420T3 DK00902627T DK00902627T DK1147420T3 DK 1147420 T3 DK1147420 T3 DK 1147420T3 DK 00902627 T DK00902627 T DK 00902627T DK 00902627 T DK00902627 T DK 00902627T DK 1147420 T3 DK1147420 T3 DK 1147420T3
Authority
DK
Denmark
Prior art keywords
trypsin inhibitor
aids
diagnosis
urinary trypsin
urinary
Prior art date
Application number
DK00902627T
Other languages
English (en)
Inventor
Marina N Papuashvili
Original Assignee
Technologie Integrale Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technologie Integrale Ltd filed Critical Technologie Integrale Ltd
Application granted granted Critical
Publication of DK1147420T3 publication Critical patent/DK1147420T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00902627T 1999-01-26 2000-01-24 Urintrypsininhibitor til diagnosticering af AIDS DK1147420T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19903034 1999-01-26
DE19920704A DE19920704C1 (de) 1999-01-26 1999-05-05 Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
EP00902627A EP1147420B1 (en) 1999-01-26 2000-01-24 Urinary trypsin inhibitor to diagnose aids

Publications (1)

Publication Number Publication Date
DK1147420T3 true DK1147420T3 (da) 2004-11-29

Family

ID=26051490

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00902627T DK1147420T3 (da) 1999-01-26 2000-01-24 Urintrypsininhibitor til diagnosticering af AIDS

Country Status (11)

Country Link
US (1) US6242197B1 (da)
EP (1) EP1147420B1 (da)
JP (1) JP3534703B2 (da)
AT (1) ATE271225T1 (da)
AU (1) AU770114B2 (da)
CA (1) CA2361000C (da)
DE (2) DE19920704C1 (da)
DK (1) DK1147420T3 (da)
ES (1) ES2225081T3 (da)
PT (1) PT1147420E (da)
WO (1) WO2000045175A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832155B1 (fr) * 2001-11-09 2004-07-09 Lab Francais Du Fractionnement Anticorps stimulant la production d'il-1ra
WO2005040222A1 (en) * 2003-10-16 2005-05-06 Bayer Healthcare Llc Monoclonal antibodies for detection of urinary trypsin inhibitors
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
EP4114428A1 (en) 2020-03-05 2023-01-11 Diamedica USA Inc. Ulinastatin polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
JPH05304983A (ja) * 1992-04-27 1993-11-19 Nissin Food Prod Co Ltd ヒト尿中蛋白質分解酵素阻害蛋白質の定量のための物質および定量方法

Also Published As

Publication number Publication date
PT1147420E (pt) 2004-12-31
AU770114B2 (en) 2004-02-12
JP3534703B2 (ja) 2004-06-07
ES2225081T3 (es) 2005-03-16
DE60012140T2 (de) 2005-09-08
ATE271225T1 (de) 2004-07-15
US6242197B1 (en) 2001-06-05
DE60012140D1 (de) 2004-08-19
EP1147420A1 (en) 2001-10-24
CA2361000A1 (en) 2000-08-03
AU2439600A (en) 2000-08-18
EP1147420B1 (en) 2004-07-14
DE19920704C1 (de) 2000-08-31
WO2000045175A1 (en) 2000-08-03
JP2002535679A (ja) 2002-10-22
CA2361000C (en) 2009-12-22

Similar Documents

Publication Publication Date Title
BR0317715A (pt) Composições e processos de uso de collajolie
DK1147420T3 (da) Urintrypsininhibitor til diagnosticering af AIDS
DK1268847T3 (da) Ubiquitin-ligaseassay
DK0833839T3 (da) Heterocykliske peptidylforbindelser, der er nyttige til behandling af thrombinrelaterede sygdomme
UY27972A1 (es) Derivados de hidantoína
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
BRPI0515776A (pt) auxiliares de retenção e drenagem
BR0215405A (pt) Composições e processos de uso de collajolie
PT1473036E (pt) Solvato de hemitartarato de zolpidem
NO20044898L (no) Nye etonogestrel estere
ATE366569T1 (de) Verwendung von cox-2 inhibitoren als immunostimulantien zur behandlung von hiv oder aids
DE69818510D1 (de) Neue verbindungen
BR9809848A (pt) Composição
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
DK1392355T3 (da) Anvendelse af proteasominhibitorer tilbehandling af öjentörhedslidelser
WO2003084384A3 (en) Diagnosis of flavivirus infection
AU5628800A (en) Substituted benzamide inhibitors of rhinovirus 3c protease
TR200102448T2 (tr) COPD tedavisi için kontrollu salma formülasyonu.
ATE315380T1 (de) Epothilon zusammensetzungen
BR0110902A (pt) Inibidores de mmp-9/mmp-2
NO20001548L (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
NO20033921L (no) Inhibitor av monoaminopptak
DE69930844D1 (de) Inhibitoren von mycobakterien
DE60122898D1 (de) Aldosteronantagonist und cyclooxygenase-2 hemmer-kombinationstherapie zur verhinderung oder behandlung von entzündungsverwandten kardiovaskulären krankheiten